USP Column - Improving patient identification
Yuflyma Demonstrates Continued Interchangeability with Humira
Results are from an open-label extension of a phase 3 trial assessing the pharmacokinetics, efficacy, safety, and immunogenicity of adalimumab-aaty and its reference formulation Humira.
The Current State Of OTC Medication Use for Pain Management
Leveraging his expertise in pain management, Mark Garofoli, PharmD, MBA, BCGP, CPE, CTTS, joined Drug Topics to discuss the importance of pharmacists in patients’ use of OTC medications to treat pain.
Significant Barriers Exist in General Practice Independent Pharmacist Prescribing
Researchers explored the confidence, barriers, and role of general practice independent pharmacists regarding prescribing services within primary care settings.
How LucyRx is Changing the Traditional PBM Model
LucyRx is empowering pharmacists and impacting patients’ health outcomes with its business model unlike other market-leading pharmacy benefit managers.
Naloxone Training Varies at Independent, Chain Pharmacies
Researchers identified differences in naloxone training, policies, procedures, and preferences among chain or independent pharmacies across Alabama.
Q&A: Medicare Price Negotiations Put Pharmacies, Patient Access at Risk | AAP 2025
A discussion with Douglas Hoey, RPh, MBA, CEO of NCPA, at AAP 2025.
